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Severe occlusive disease of the supraaortic trunks
(SAT) is managed by transthoracic, extraanatomic
cervical or endovascular repair. The natural history
of these lesions is not well known because they are
relatively uncommon and because they are difficult
to image using noninvasive technology (duplex,
magnetic resonance angiography). There are, how-
ever, well-recognized ischemic manifestations of
occlusive disease of the SAT in the hemispheric, ocu-
lar, vertebrobasilar, and arm territories that may lead
to stroke or to digital gangrene. Repair of occlusive
lesions of the SAT accounts for less than 10% of the
operations performed on the extracranial arteries of
cerebral destination.1-3
Over the past 16 years we have preferred direct,
transthoracic reconstruction over cervical repair for
innominate artery (IA) occlusion and for complex
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Purpose: This is a review of 100 consecutive supraaortic trunk reconstructions (SAT)
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extremity ischemia in four. Thirteen patients were asymptomatic. An innominate lesion
was bypassed in 78 cases. The left common carotid and left subclavian arteries required
reconstruction in 38 and nine patients, respectively. Multiple trunks were reconstructed
by direct bypass grafting in 35. Approach was via median sternotomy in 92, partial ster-
notomy in six, and left thoracotomy in two. Seven patients underwent concomitant car-
diac surgery.
Results: Eight deaths and eight nonfatal strokes occurred, for a combined stroke/death
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operations. Perioperative complications included two asymptomatic graft occlusions,
three nonfatal myocardial infarctions, seven significant pulmonary complications, three
sternal wound infections, and one recurrent laryngeal nerve injury. Follow-up ranged
from 1 to 184 months (mean, 51 6 4.8 months). Eight patients were lost to follow-up.
Twenty-one late deaths occurred. Two SATs required late revision. The cumulative pri-
mary patency rates at 5 and 10 years were 94% 6 3% and 88% 6 6%, respectively. The
stroke-free survival rates at 5 and 10 years were 87% 6 4% and 81% 6 7%, respectively.
Patients who survived beyond 30 days had a median stroke-free life expectancy of 10
years, 7 months (SE, 6%).
Conclusions: Direct reconstruction of complex symptomatic SAT lesions can be per-
formed with acceptable death/stroke rates and with long-term patient benefit.
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IA and common carotid artery (CCA) lesions in
patients who are reasonable cardiopulmonary risks.
Single CCA or subclavian lesions, in cases in which
adequate inflow is available, have generally been cor-
rected through a cervical approach. Lately, a few
selected cases (not reported here) have been recon-
structed using an endovascular technique.
Most papers that deal with the surgical treatment
of SAT disease combine data from both cervical and
thoracic approaches together.4-8 Often, comparisons
cannot be made between transthoracic and cervical
repairs because the characteristics of the atheroscle-
rotic lesions (multiple versus single, flow-restricting
versus embolizing) fairly mandate one approach or
the other. Single lesions of the subclavian artery or
CCA are best treated with a cervical operation,
whereas combined IA and left CCA disease often
requires a thoracic approach. Likewise, embolizing
lesions of the IA usually require transthoracic repair
because the most appropriate exclusion of an embol-
ic source may not be possible from a cervical
approach. On the other hand, single, stenosing dis-
ease of the IA may be repaired via either a thoracic
or a cervical operation, the latter via a contralateral
bypass graft to the right CCA. The patient’s car-
diopulmonary risk, previous operations, radiation,
or infection may also determine the choice of oper-
ation. A previous mediastinotomy performed for
myocardial revascularization or the presence of
severe pulmonary disease substantially increases the
risk of a thoracic approach. In other cases, the prob-
lem may be corrected equally well by either a
transthoracic or a cervical approach. It is pertinent
then to know the short-term and long-term history
of transthoracic, cervical, and endovascular repairs.
With substantial experience limited to a few large
medical centers, the indications for direct, transtho-
racic repair of the SAT have been derived from
assumptions on the basis of the natural history of
their atherosclerotic involvement. Survival and long-
term patency data are limited after such reconstruc-
tions. To contribute to the study of risk/benefit on
this subject, we undertook this retrospective analysis.
PATIENTS AND METHODS
Patients. Over a 16-year period (1981 through
1996), 100 transthoracic reconstructions for occlu-
sive disease of the SAT were performed. Patient
medical records were reviewed in detail, and exten-
sive efforts were made to update graft patency and
patient survival data.
The 100 reconstructions were performed in 98
individuals and included eight innominate endar-
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terectomies and 92 aorta or IA-based bypass proce-
dures. Fifty-six patients were female, and 44 were
male. The mean patient age was 61 6 9.5 years, with
ages ranging from 24 to 79 years.
The vast majority of patients (98%) were treated
primarily for atherosclerotic disease involving one or
more of the SATs. One young patient required
reconstruction after a traumatic dissection that re-
sulted in symptomatic IA occlusion. One patient
underwent an IA bypass procedure for a chronic and
symptomatic occlusion that followed a remote car-
diac embolic event.
Cerebrovascular ischemia, defined as hemispher-
ic, monocular, or vertebrobasilar transient ischemic
attack or stroke, attributable to SAT lesions occurred
alone or in any combination in 83 patients (83%).
Thirty patients (30%) had a hemispheric stroke
before undergoing revascularization. In 14 patients
(14%) a hemispheric stroke was the primary indica-
tion for operation. An additional 16 patients (16%)
had a remote history of stroke (longer than 1 year).2
Arm symptoms were present in five patients
(5%). Four of them had exclusively upper extremity
ischemic symptoms. Two patients had limb claudica-
tion, whereas three patients had significant ulcera-
tion or necrosis of the finger(s).
Thirteen patients (13%) were asymptomatic.
One of them was found to have a silent hemispheric
infarct on a preoperative computed tomographic
scan. Patient symptoms are summarized in Table I.
Forty-five patients (45%) had significant cardiac
disease, and nine of them had previously undergone
a median sternotomy for coronary revascularization
(seven patients), valve repair (one), or resection of a
ventricular aneurysm (one). Seventy-two patients
(72%) were undergoing treatment for hypertension.
Significant pulmonary dysfunction was present in 13
patients (13%). Fourteen patients (14%) had dia-
betes, and five patients had renal failure (5%). Three
patients had undergone previous head and neck irra-
diation. Ninety-six patients (96%) had a significant
smoking history. Forty patients (40%) had signifi-
cant aortoiliac (12%) or femoropopliteal (28%)
occlusive disease.
Before diagnosis and repair of their SAT lesions,
37 patients (37%) had undergone a total of 61 cere-
brovascular reconstruction procedures. These oper-
ations included four transthoracic SAT operations,
42 carotid bifurcation endarterectomies, and 15
CCA, vertebral artery, or subclavian artery recon-
structions.
Results of a preoperative computed tomographic
scan of the brain were available in 72 patients (72%),
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of which 51 were normal (51%), 18 showed a hemi-
spheric infarction (18%), and three showed an
infarction in the vertebrobasilar territory (3%).
All 100 patients underwent preoperative four-
vessel arteriography. The most common indication
for diagnostic arteriography was the association of
cerebral ischemic symptoms and a positive result of
a duplex scan of the carotid bifurcation. Cervical or
supraclavicular bruits, radial or temporal pulse
deficits, and upper extremity blood pressure differ-
ential readings also contributed to the clinical diag-
nosis of SAT disease.
At angiography, severe disease was defined as
stenosis >75% diameter or, in symptomatic patients,
a deep ulceration within a plaque or the presence of
thrombus within the arterial lumen. The IA was the
vessel most commonly involved with disease. In 78
patients (78%) the IA had severe disease; 18 patients
(18%) had occlusion, 36 patients (36%) had >75%
diameter stenosis, and 24 patients (24%) had ulcer-
ated or irregular atheromata that was thought to be
the source of ipsilateral hemispheric events.
The left CCA was severely diseased in 50 patients
(50%) and was reconstructed in 38 cases (38%). The
most common reason not to reconstruct the left
carotid system was left internal carotid artery occlu-
sion. The left subclavian artery was significantly dis-
eased in 52 patients (52%) but was reconstructed in
only nine patients (9%). Reconstruction was not per-
formed for asymptomatic left subclavian artery dis-
ease.3
Sixty-three patients (63%) had multiple SAT
lesions. All three SATs were diseased in 22 patients
(22%), and two of three were significantly involved in
41 patients (41%). Only a single SAT vessel was
involved with disease in 37 patients (37%), and it was
the IA in 28 instances. There was arteriographic evi-
dence of vertebral steal in 25 patients (25%).
Thirteen patients with radiographic steal had verte-
brobasilar symptoms. Twenty-five patients (25%) had
significant (>60%) carotid bifurcation stenosis.
Surgical repair. Innominate endarterectomy was
used only during the early years. Later, bypass graft-
ing became the preferred technique. Our standard
technique for transthoracic repair of the SAT has
been described elsewhere.9 Our policy for revascu-
larization was to reconstruct any trunk that was pre-
sumed to be symptomatic and those anterior trunks
that were severely diseased. Asymptomatic severe
lesions of the left subclavian artery were not repaired
unless it was needed for a left internal mammary
myocardial revascularization procedure. Synchronous
severe lesions of the carotid bifurcation were gener-
ally corrected at the time of operation if they were
ipsilateral to the patient’s SAT reconstruction or
were potentially a cause for the patient’s symptoms.
Contralateral and severe carotid bifurcation lesions
were corrected at another time based on their own
merits.
The brain was a target for revascularization in all
cases. There were 33 aortoinnominate bypass proce-
dures (33%), 8 IA endarterectomies (8%), and 28
bypass procedures in which the graft originated from
the ascending aorta (28%), with one branch to the
right (10 grafts), left (eight), or both (10) carotid
systems. In addition, there was one bypass graft from
the descending thoracic aorta to both carotid bifur-
cations and one graft replacement of the transverse
segment of the arch of the aorta with left CCA and
subclavian branches.
There were 15 aortoinnominate bypass grafts
with a side limb to the left carotid system (14 grafts)
or to the left subclavian artery (one). There were six
aortocarotid bypass grafts with a limb to a subclavian
artery. There was a single aorta–left subclavian artery
bypass graft and a single aortovertebral bypass graft
to revascularize the brain through a single vertebral
artery in two patients who had bilateral internal
carotid occlusion. In addition, there were six bypass
procedures based on the proximal IA: four to the
right carotid artery, one to the left subclavian artery,
and one bifurcated graft to the right carotid and sub-
clavian arteries. In total, there were 57 straight grafts
and 35 with multiple limbs.
The reconstruction was performed through a full
median sternotomy in 92 cases, a partial median ster-
notomy in six, and a left thoracotomy in two.
Because of previous cardiac or SAT interventions, in
13 patients (13%) the full median sternotomy was a
redo procedure. A partial median sternotomy involv-
ing the upper half of the sternum was used in six IA
endarterectomies performed for lesions of the distal
half of the IA. In 10 patients the carotid bifurcation
operation performed concomitantly with the SAT
repair was a reoperation. Autologous vein was used
Table I. Clinical presentation and symptoms
No. of patients
Ocular only 14
Hemispheric only 16
Vertebrobasilar only 25
Arm only 4
Hemispheric + ocular 9
Hemispheric + vertebrobasilar 18
Hemispheric + arm 1
No symptoms 13
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as conduit in two cases, expanded polytetrafluo-
roethylene was used in 66, and Dacron in 24.
Seven patients (7%) underwent a concomitant
cardiac operation at the time of SAT reconstruction.
Six patients underwent revascularization of their
coronary arteries, and one patient underwent con-
comitant mitral valve replacement. All of the patients
who underwent a cardiac procedure initially had
cerebrovascular symptoms that arose from their SAT
lesions and were found to have severe cardiac prob-
lems on further evaluation.
There were two intraoperative acute bleeding
events without adverse consequences that occurred
while reopening the sternum. Both occurred in
patients who had undergone at least one previous
midsternotomy. One patient had a small tear devel-
op in the right ventricle. In the other patient, a
chronically occluded aortoinnominate artery bypass
graft tore away from the ascending aorta. In both
instances the bleeding was controlled by direct
repair.
The brachiocephalic vein was divided in six cases
to improve exposure. It was ligated in five cases and
reconstructed in one.
In addition to the 100 direct SAT reconstruc-
tions, 43 additional procedures were performed in
the same setting in 39 patients who had complex
SAT disease and further atherosclerotic lesions
downstream. Carotid bifurcation endarterectomy
was performed concomitantly with SAT reconstruc-
tion in 26 patients (26%) either as a remote compo-
nent to the operation or incorporated into the distal
anastomosis of the bypass graft. A vertebral artery
was transposed or bypassed in five cases (5%). A sep-
arate reconstruction was performed to repair a dis-
eased subclavian artery (nine) or CCA (three) in 12
cases.
Blood loss averaged 866 6 57 ml, and an aver-
age of 1.2 6 0.17 units of blood were transfused.
Postoperative angiograms were obtained for all
patients during the index hospitalization before dis-
charge.
The average duration of hospital stay was 10.5 6
0.79 days, and patients remained in the intensive
care unit for 4 days on average (SEM, 0.42).
RESULTS
The combined stroke/death rate was 16%. There
were eight perioperative deaths (8%). Six deaths
(6.4%) occurred in the 93 patients who underwent
reconstruction of the SAT alone. Two deaths
(28.5%) occurred in the seven patients who under-
went a simultaneous cardiac/SAT procedure.
Among the 93 patients who underwent reconstruc-
tion of the SAT alone, there were 13 asymptomatic
patients (no deaths) and 80 symptomatic patients
(six deaths). The statistical difference between these
two groups is not significant (p = 0.59). A single
nonfatal stroke occurred amongst the asymptomatic
population.
Two deaths were directly related to cerebral
infarction. One patient had a massive stroke on the
seventh postoperative day in a distribution con-
tralateral to the SAT reconstruction. This stroke was
attributed to embolization from a known atrial
thrombus in a patient with active fibrillation. The
SAT repair was patent at the time of the patient’s
death. The second stroke death was the result of a
Fig. 1. Overall SAT cumulative survival data.
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sudden, large intracranial bleed on the fourth post-
operative day while the patient was ambulatory and
ready for discharge. Before operation this woman
was symptomatic and had an occluded aortoinnom-
inate bypass graft that had been implanted elsewhere
11 years previously. Her left CCA and subclavian
artery were occluded as well. We performed a sec-
ond aortoinnominate bypass procedure. The post-
operative cerebral hemorrhage appeared to be the
result of cerebral hyperperfusion. Again, the bypass
graft was patent at the time of death.
The remaining six deaths followed cardiorespi-
ratory complications. One patient who underwent a
concomitant and complicated coronary revascular-
ization procedure had an intraoperative myocardial
infarction. This patient could not be weaned from
cardiopulmonary bypass and died in the operating
room. A second patient who underwent a com-
bined coronary/SAT procedure had an accidental
air embolus during the operation and died on the
first postoperative day. The remaining cardiorespi-
ratory deaths occurred on postoperative days 2, 4,
8, and 9. The first two followed massive myocardial
infarctions in patients with known coronary artery
disease, the third was the result of a pulmonary
embolus, and the fourth was precipitated by a car-
diac arrhythmia.
Eight nonfatal strokes occurred during the peri-
operative period. One patient had occipital bleeding
on the fourth postoperative day. The reconstruction
was patent, and the intracranial hemorrhage was
attributed to hyperperfusion. This patient was treat-
ed by surgical evacuation of the hemorrhagic tissue
and recovered normal neurologic function in 2
weeks. Two of the eight strokes were a result of peri-
operative graft occlusion. The single aortovertebral
bypass graft occluded on postoperative day 5; this
was the result of vein graft impingement by adjacent
structures in the thoracic outlet. The bypass graft
was revised, and the mediastinal path was corrected.
Hemianopsia developed as a result of a small occipi-
tal infarction. Another patient had thrombosis of an
aorta–left CCA bypass graft on postoperative day
three and had a minor stroke. The graft was
replaced, and the patient’s deficit had disappeared by
the time of discharge. One patient had a stroke while
at home on postoperative day 15. This stroke result-
ed from a known significant contralateral internal
carotid artery stenosis that was scheduled to be
repaired. Blindness and superior vena cava syndrome
developed in one patient after repair of a large tear
that occurred at the brachiocephalic-caval venous
junction during exposure of the anterior medi-
astinum. A technically successful juguloatrial bypass
procedure corrected the patient’s superior vena cava
syndrome, but her blindness persisted. Three post-
operative strokes occurred for which no specific eti-
ologic mechanism could be identified after emer-
gency arteriography. All of the patients who had
nonfatal strokes were included in long-term graft
patency data and in survival analyses.
There were, in addition, two asymptomatic graft
occlusions. One was cleared by thrombectomy and
revised; the other (occlusion of a subclavian limb)
was left untreated. The three patients who had
grafts that failed and were revised within 30 days of
Fig. 2. SAT reconstruction patency data.
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(mean, 51 ± 4.8 months). Thirty-four patients were
available for follow-up at 5 years, and 10 patients
were available at 10 years. Follow-up data on long-
term graft patency was obtained by physical exami-
nation, by indirect Doppler waveform analysis of the
carotid and upper extremity circulation, by direct
duplex ultrasound interrogation of the reconstruc-
tion, or by angiogram.
Twenty-one patients (21%) died during follow-
up. One patient died during a coronary artery
bypass grafting procedure at 88 months, and one
patient died during abdominal aortic aneurysm
repair at another institution at 52 months. A fourth
patient died of a stroke 16 months after an
aorta–left carotid artery bypass procedure; it is not
known whether the graft was patent at the time of
death. There were seven late cardiac deaths at 30,
31, 48, 55, 55, 66, and 122 months. Three cancer-
related deaths occurred at 18, 48, and 110 months,
and one death from pneumonia occurred at 77
months. The remaing seven deaths from unknown
causes occurred at 3, 4, 20, 60, 60, 106, and 120
months. It is known that the one death that
occurred at 3 months took place at in-patient reha-
bilitation in the patient who had required treatment
for adult respiratory distress syndrome. The overall
patient survival rate was 73% and 52% at 5 and 10
years, respectively. Long-term overall patient sur-
vival statistics are summarized graphically in Fig. 1.
Two successful revascularization procedures were
performed for late failures of a bypass limb, which
caused transient ischemic attacks at 3 and 104 months
after the operation. Fig. 2 shows primary and sec-
ondary patency curves for these SAT reconstructions.
operation were followed-up late and included in
secondary patency data. The early patency of all
reconstructions was documented by a postoperative
angiogram.
There were three nonfatal perioperative myocar-
dial infarctions (3%) in patients who had known car-
diac disease. Seven nonfatal pulmonary complica-
tions (7%) were noted. These included one episode
of respiratory failure, two pneumothoraces that
required chest tube placement, two pleural effusions
that required aspiration, one case of pneumonia,
and one case of adult respiratory distress syndrome.
Three of these pulmonary complications required
prolonged (>3 days) ventilatory support. In total,
16 patients (16%) had perioperative cardiopul-
monary morbidity or died.
Two patients (2%) required a return to the oper-
ating room for evacuation of a hematoma or
drainage of a pericardial tamponade. Three wound
complications occurred; all were sternal wound
infections. Two were treated successfully with
myocutaneous flaps, whereas one required graft
removal and complex extraanatomic autogenous
reconstruction using the superficial femoral artery.
This patient is counted as a graft failure but was fol-
lowed-up for purposes of complete survival data.
Other complications included a permanent vocal
cord paresis after injury to the right recurrent laryn-
geal nerve (1%). Upper extremity swelling developed
in six patients (6%); all occurred in patients who
underwent ligation of the innominate vein. There
was one episode of lower limb ischemia and major
amputation in a patient who had heparin allergy.
Patient follow-up ranged from 1 to 184 months
Fig. 3. SAT protection from stroke
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Three patients required repeat sternotomy for
coronary revascularization at 62, 88, and 166
months after undergoing SAT bypass grafting. Two
patients had nonfatal strokes, and eight had tran-
sient ischemic attacks during late follow-up; all were
attributed to carotid bifurcation or intracranial ath-
erosclerotic disease contralateral or distal to the
patient’s SAT repair. In addition, six patients had
persistent, recurrent, or new vertebrobasilar symp-
toms severe enough to require further intervention.
Late reconstructions of the more distal extracranial
cerebral vasculature was performed when indicated
for symptomatic or asymptomatic disease. Nineteen
patients (19%) required 22 late cerebrovascular
operations for occlusive disease unrelated to SAT
bypass failure. These included 14 carotid
endarterectomies or replacements, four vertebral
reconstructions, and four left subclavian to carotid
transpositions. The ability for SAT reconstruction to
protect patients from stroke is depicted in Fig. 3.
Patients who survived beyond the 30-day perioper-
ative period had a median stroke-free life expectan-
cy of 10 years, 7 months (SE, 6%). Patency and sur-
vival curves were plotted in accordance with criteria
established by the SVS/ISCVS.10,11
DISCUSSION
In this series of patients with complex disease
involving the IA and CCA, direct reconstruction
was aimed at revascularizing the brain. In the few
cases in which the target vessel was a subclavian or a
vertebral artery, the patients had bilateral ICA
occlusions and the reconstruction was done to pro-
vide brain perfusion via the posterior circulation.
Most series that deal with the surgical treatment
of patients with IA and CCA disease include patients
who were treated using the cervical and transtho-
racic options available to the surgeon.4-8 Our alloca-
tion of patients to one or the other method of treat-
ment over the past 16 years has been generally based
on cardiopulmonary risk and on the anatomic distri-
bution of the atherosclerotic lesions. In patients
with significant cardiopulmonary risk and patients
who have previously undergone operation in the
mediastinum, we prefer a cervical approach. Those
with a single intrathoracic lesion of a CCA or sub-
clavian artery are also managed with a relatively
straightforward neck operation. On the other hand,
complex IA lesions, particularly those that are
embolizing or associated with left CCA lesions, we
have preferentially treated by direct transthoracic
exclusion bypass grafting.
The composition of the series of patients with
IA/CCA disease published in the literature varies
substantially.4-9,12-16 The rate of comorbidity in our
series is significantly higher than in the other reports
reviewed here. There are also substantial differences
in the percentage of asymptomatic patients (13% in
our series) in published reports, ranging from 8% to
32%.
The deaths in our series were primarily car-
diopulmonary. In fact, one of the two stroke deaths
also had cardiac cause—embolization of a large atri-
al thrombus. Our experience is similar to that
reported by Vogt et al.7 and by Kieffer et al.,13 who
also list cardiopulmonary complications as their
most frequent morbidity, but it differs from that of
Crawford et al.,6 who reported stroke as the most
common complication and cause of death. The mor-
tality rate of transthoracic repair varies in the report-
ed literature from 0% to 14.7%.
In the small subset described in our series that
underwent cardiac and SAT repair simultaneously,
the mortality rate was 29% (two of seven). Although
the numbers are limited, should this data preclude us
from performing both repairs simultaneously? The
causes of death in these two patients were, in one
patient, an accidental air embolus caused by a perfu-
sion error and, in the other, a complex coronary
repair that resulted in an intraoperative myocardial
infarction. None of these problems were related to
the associated SAT procedure, and other authors
have not reported a high mortality rate from the syn-
chronous performance of SAT and coronary repair.
We believe that these two procedures should be com-
bined when there are operative indications to repair
both SAT and coronary lesions.
We have traditionally viewed disease of the IA
and CCA in the same light as disease of the carotid
bifurcation. The composition and surface appear-
ance of atheromatous plaques is similar in both loca-
tions, and the mechanisms of brain injury (flow
restriction and embolization) are the same.
Regarding our indications for surgical correction, we
have slightly stricter criteria for operating on asymp-
tomatic lesions of the SAT (>75% diameter stenosis)
than we do for operating on asymptomatic lesions of
the carotid bifurcation. We necessarily take into
account the increased magnitude and risk attending
the former operation. The ACAS study has shown
prospectively the benefits of operating on asympto-
matic lesions of the internal carotid artery with
>60% diameter stenosis when the combined mor-
bidity/mortality rate is less than 3.0%.17 The life
expectancy of the patients in our series is similar to
that of patients with carotid bifurcation disease—
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approximately 50% of them are dead 10 years after
surgical repair, mostly from cardiac disease.
Although none of the asymptomatic patients in this
series died, their number is too small to be statisti-
cally valid. In considering indications for operation,
we should apply the mortality rate of the entire
group (with and without symptoms), which was
6.4% and consisted mostly of cardiac problems. Even
if we assume that the asymptomatic patients with
IA/CCA disease may have less-advanced coronary
disease than those who have symptomatic IA/CCA
lesions, the risk of transthoracic repair probably
negates the long-term stroke-sparing benefit it has
over their limited life expectancy. On the other
hand, in patients who have ischemic brain symp-
toms, a direct transthoracic reconstruction is an
effective curative operation that at 5 years has a
cumulative primary patency rate of 94% and a
stroke-free survival rate of 87%.
Cervical repair of atherosclerotic SAT disease
may be inappropriate when the lesions are complex
or multiple; however, when a cervical operation is
possible, the patient mortality rate is less than 2%.
Limited experience with endovascular repair antici-
pates that its long-term results may be inferior to
those obtained by direct anatomic bypass recon-
struction. Long-term patency goals, however, are
less relevant in a population in which 50% will not
survive a decade. The immediate morbidity and
mortality rates of endovascular repair remain to be
determined.
CONCLUSION
Direct transthoracic repair of lesions of the IA and
CCA is not recommended in patients without neuro-
logic symptoms because the morbidity rate of the
operation is probably greater than that of the natural
course of the atherosclerotic disease. In these patients,
consideration should be given to cervical surgical
repair or to endovascular techniques that carry a lower
perioperative mortality rate, even if their long-term
patency and stroke-free survival rates are inferior or
unknown. Patients who have symptomatic lesions of
the IA (with/without associated CCA disease) benefit
from direct transthoracic repair and can expect long-
term protection from stroke.
We thank Ms. Michele Messina for her assistance in
the preparation of this manuscript.
DISCUSSION
Dr. Luis A. Queral (Baltimore, Md.). Dr. Berguer
has just presented a clear, concise, and well-documented
paper outlining his 16-year experience with largely
transsternal supraaortic trunk reconstructions. I congrat-
ulate him and his colleagues for this achievement. The
surgical mortality rate, as noted, was 6.4% when recon-
structions were carried out alone and 29% when com-
bined with a cardiac operation. An 8% operative stroke
rate was reported. The long-term patency rate of the
reconstruction was a commendable 94% at 5 years and
88% at 10 years, with a stroke-free survival rate of 87%.
There is no question regarding the durability of the
reported traditional surgical approach. However, I would
question the relevancy of long-term goals in a population
in which 50% of the patients will not survive a decade. Is
long-term patency worth the significant operative mortal-
ity rate of 6.4%, or even that of 29% when combined with
cardiac surgery? Can a perioperative stroke rate of 8% be
improved on? Is it, in fact, tolerable? What is the alterna-
tive? What does an endovascular approach offer in these
complicated cases that Dr. Berguer reported on?
Well, let’s examine the patients treated and their
lesions to determine their suitability for endovascular
repair. The 78 patients who were treated for innominate
artery occlusive disease had obstructions in 18 cases—I
don’t know the length of these obstructions, but I assume
that most of them were short, as is usually the case—36 of
these patients had innominate artery stenosis >75%, and
24 of these patients had an ulcerated innominate artery or
irregular atheromatous plaques.
There were 50 patients with severe left common
carotid artery disease, 38 of whom underwent reconstruc-
tion, and 52 patients with subclavian artery disease under-
went nine reconstructions. Even when you exclude a per-
centage of the patients with innominate artery occlusions,
it appears that the vast majority of patients in this series
could have been treated by placement of a stent at the site
of the offending lesion. This endovascular approach, when
performed in an operating room setting with a cervical
cutdown allowing retrograde deployment and avoiding
embolization, has a much lower morbidity and mortality
rate and a hospital stay approximately 9 days shorter.
I do realize that stenting the supraaortic trunks may not
be as durable, but is it not justified considering the marked-
ly shortened lifespan of most of these patients? Why not
treat all patients initially with endovascular stenting and
perform the highly morbid traditional surgical approach
in cases of recurrence or failure? We as vascular surgeons
have a unique opportunity to change our approach to
patients who have supraaortic trunk occlusive disease.
Dr. Ramon Berguer. I agree with Dr. Queral that for
asymptomatic patients an endovascular procedure certain-
ly seems like a more reasonable option. I think if we con-
sider the natural history of the disease in individuals who
are actively symptomatic from innominate and carotid dis-
ease, the option of an operation that carries a 6.4% mor-
tality rate is not a bad one. After all, we have very little or
no information on the outcome of endovascular proce-
dures in patients who are actively symptomatic.
Dr. Malcolm O. Perry (Dallas, Tex.). Dr. Berguer, I
enjoyed the presentation very much. It was elegant as
always. I have one question for you. Those of us who per-
form these complex procedures, like you, prefer a single
entry from the ascending aorta and the attachment of
branches as needed. You mentioned one patient who died of
hyperperfusion syndrome several days later. We have all seen
that problem. Do you have any advice for us in these oper-
ations, that is, should one stage them or do all of the grafts
at once? It has been my practice to correct all of them at one
sitting. And I have seen this problem. Could you enlighten
us to what you think may be the mechanism of this syn-
drome, and would we do better to stage them rather than
to perform the complete operation at the first sitting?
Dr. Berguer. As we all know, strokes6 occur usually
on days 3 through 5. I don’t know that it is preventable
by the means that we’re using now, but we are controlling
the systolic pressure to the point where we will not let it
rise above 110, and we’re giving steroids to these patients.
The steroids have certainly been proven to control edema
in the spinal cord in trauma. Because there is a certain
similarity between the spinal cord tissue and the tissue we
are discussing here, I thought it reasonable to give these
patients steroids.
Whether to reconstruct one trunk or three trunks, I’m
not sure that there is a terrible amount of difference. I’m
not sure there is any difference whatsoever in the intracra-
nial pressure when you reconstruct an innominate artery or
an innominate artery and a left common carotid artery. I
think the end pressure that you get is just about the same.
Dr. Thomas S. Riles (New York, N.Y.). I appreciat-
ed the paper very much, Dr. Berguer. I always learn a
great deal from your presentations. In the strokes that you
reported, you found the cause in all but three. I’m curi-
ous to know whether these were strokes that could have
been caused by poor perfusion during the time of the
reconstruction or clamping of the artery. For that reason,
I ask, do you have any means of monitoring the cerebral
blood flow, and if you find that there is diminished blood
flow during that period of time, do you use a shunt?
Dr. Berguer. No, I don’t use any method of monitor-
ing the blood flow. We have used a shunt if we have to
clamp the only patent vessel available for reconstruction,
but otherwise we don’t. I think the strokes were probably
caused by debris from either the graft or the anastomotic
site. They were very discrete. I obtained an angiogram but
found absolutely nothing wrong with the grafts. I presume
they were caused by embolic disease, but I am not certain
about it.
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